Exact Mass: 499.081813

Exact Mass Matches: 499.081813

Found 30 metabolites which its exact mass value is equals to given mass value 499.081813, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

VX-11e

4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide

C24H20Cl2FN5O2 (499.0978012)

VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.

CDK9 inhibitor

N-[5-({6-[3-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)phenyl]pyrimidin-4-yl}amino)-2-methylphenyl]methanesulphonamide

C26H21N5O4S (499.1314186000001)

Glucose lactate pyruvate glutamate

2-Amino-5-[(2-hydroxypropanoyl)peroxy]-5-oxo-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanoyl 2-oxopropaneperoxoic acid

C17H25NO16 (499.11732900000004)

Palygorskite

Dialumane tetradecahydric acid dimagnesium tetrasilane hydroxide

Al2H45Mg2O15Si4 (499.116726)

It is used in foods as a clarifying and flocculating agent [DFC]

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

C19H21N3O9S2 (499.07191760000006)

Fosquidone

C28H22NO6P (499.11846820000005)

C274 - Antineoplastic Agent > C177298 - Mitochondrial Targeting Antineoplastic Agent C26170 - Protective Agent > C275 - Antioxidant

4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide

C23H21N3O8S (499.10493060000005)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

C13H19N5O12P2 (499.0505434)

5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate

C17H25NO16 (499.11732900000004)

(7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H21N3O10S3 (499.0389046)

[(e)-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trimethoxyphenyl)ethylidene)amino]oxysulfonic acid

C17H25NO12S2 (499.081813)

7,17-dihydroxy-12-(3-hydroxy-4-methoxyphenyl)-8,16-dimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one

C28H21NO8 (499.1267106)

(6r,7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H21N3O10S3 (499.0389046)

(6s,7s)-1,6,10,15,16-pentahydroxy-7-methoxy-3,11-dimethyl-6,7-dihydro-2-azahexaphene-9,14-dione

C28H21NO8 (499.1267106)

Exact Mass: 499.081813

Exact Mass Matches: 499.081813

VX-11e

CDK9 inhibitor

Glucose lactate pyruvate glutamate

Palygorskite

3,4,5-Trimethoxybenzyl glucosinolate

Antibiotic SF 1623

Ericamycin

Lamellarin N

Lamellarin D

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

Fosquidone

4-nitrobenzyl [2R-(2alpha,5beta,6alpha,7beta)]-3-methylene-8-oxo-7-(phenoxyacetamido)-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylate 5-oxide

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-Hexanesulfonamide

Satraplatin

Sodelglitazar

C17H25N9O3S3

Cdk9-IN-1

Azane;cyclohexanamine;platinum(4+);diacetate;dichloride

n-[4-[[Glutamic acid]-carbonyl]-benzene-sulfonyl-d-prolinyl]-3-amino-propanoic acid

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

5-O-(2-hydroxypropanoyl) 1-O-(2-oxopropanoyl) 2-amino-2-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]pentanediperoxoate

[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone

3-[[2-[[5-[(4-Cyanophenoxy)methyl]-4-phenyl-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]benzoic acid methyl ester

4-(4-Chlorobenzoyl)-1-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-5-phenylpyrrolidine-2,3-dione

(R)-VX-11e

(7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

[(e)-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trimethoxyphenyl)ethylidene)amino]oxysulfonic acid

7,17-dihydroxy-12-(3-hydroxy-4-methoxyphenyl)-8,16-dimethoxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-2(11),5(10),6,8,12,14(19),15,17,20-nonaen-3-one

(6r,7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6s,7s)-1,6,10,15,16-pentahydroxy-7-methoxy-3,11-dimethyl-6,7-dihydro-2-azahexaphene-9,14-dione